Elena Vissio, MD

I graduated in Medicine and Surgery in 2017 at the University of Turin, Italy. After that, I enrolled as a Pathology resident. Alongside with the diagnostic activity, I focused on the study of prognostic and predictive markers in cancer. In 2021, I began a PhD in Turin to pursue my research interests in the cancer field. I joined Chiarle’s Lab to study the mechanisms of resistance to ALK target therapies and to investigate new potential therapeutic targets to overcome such resistance.